Giselle Mosnaim, MD

Articles by Giselle Mosnaim, MD

Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous Urticaria

ByEmma Andrus, Associate Editor,Giselle Mosnaim, MD

March 13th 2024

Allergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Latest Updated Articles

Giselle Mosnaim, MD

Articles by Giselle Mosnaim, MD

Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous Urticaria

Latest Updated Articles

Trending on Dermatology Times

How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level

25 Years Later: Remembering September 11 Through the Lens of Dermatologic and Burn Care

Isotretinoin Use in Adolescence Not Linked to Reduced Adult Height

Diet Linked to Improved Chronic Idiopathic Urticaria Control

Q&A: Steve Yoelin, MD, on the Evolving Regulatory Landscape for Masseter Toxin